Literature DB >> 23352489

Roles of miR-1-1 and miR-181c in ventricular septal defects.

Jian Li1, Yinyin Cao, Xiao-jing Ma, Hui-jun Wang, Jin Zhang, Xin Luo, Weicheng Chen, Yao Wu, Yingying Meng, Jing Zhang, Yuan Yuan, Duan Ma, Guo-ying Huang.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are endogenous noncoding RNAs of approximately 22 nucleotides in length that mediate post-transcriptional gene silencing by annealing to sequences in the 3'-untranslated region of target mRNAs.
METHODS: In this study, we analyzed 25 candidate miRNAs selected based on microarray data for cardiac tissue from individuals with congenital heart defects (CHDs) and from healthy control tissue.
RESULTS: This study identified specific changes in the miR-1-1 and miR-181c levels in human cardiac samples from individuals with ventricular septal defects (VSDs) relative to the levels in healthy control tissue. Increased levels of GJA1 and SOX9 were associated with the decreased expression of miR-1-1 in VSD patients, and increased miR-181c expression was correlated with downregulated BMPR2 levels. In addition, the results revealed that miR-1-1 and miR-181c directly regulate the expression of these predicted targets.
CONCLUSIONS: miR-1-1 and miR-181c are associated with the pathogenesis of VSDs.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  BMPR2; GJA1; SOX9; Ventricular septal defect; miR-1-1; miR-181c

Mesh:

Substances:

Year:  2013        PMID: 23352489     DOI: 10.1016/j.ijcard.2012.12.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  23 in total

Review 1.  MicroRNAs: pleiotropic players in congenital heart disease and regeneration.

Authors:  Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects.

Authors:  Wan-Qin Xie; Lin Zhou; Yong Chen; Bin Ni
Journal:  World J Emerg Med       Date:  2016

3.  MicroRNA expression, target genes, and signaling pathways in infants with a ventricular septal defect.

Authors:  Hui Chai; Zhaoyuan Yan; Ke Huang; Yuanqing Jiang; Lin Zhang
Journal:  Mol Cell Biochem       Date:  2017-08-18       Impact factor: 3.396

4.  miR-10a and miR-10b target the 3'-untranslated region of TBX5 to repress its expression.

Authors:  Feng Wang; Xue-Yan Yang; Jian-Yuan Zhao; Li-Wei Yu; Ping Zhang; Wen-Yuan Duan; Mei Chong; Yong-Hao Gui
Journal:  Pediatr Cardiol       Date:  2014-04-09       Impact factor: 1.655

5.  MicroRNAs Association in the Cardiac Hypertrophy Secondary to Complex Congenital Heart Disease in Children.

Authors:  Ma C Sánchez-Gómez; K A García-Mejía; M Pérez-Díaz Conti; G Díaz-Rosas; I Palma-Lara; R Sánchez-Urbina; M Klünder-Klünder; J A Botello-Flores; N A Balderrábano-Saucedo; A Contreras-Ramos
Journal:  Pediatr Cardiol       Date:  2017-04-05       Impact factor: 1.655

Review 6.  Role of miR-181 family in regulating vascular inflammation and immunity.

Authors:  Xinghui Sun; Alan Sit; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2013-11-01       Impact factor: 6.677

Review 7.  Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling.

Authors:  Kondababu Kurakula; Marie-Jose Goumans; Peter Ten Dijke
Journal:  EXCLI J       Date:  2015-07-10       Impact factor: 4.068

8.  Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital.

Authors:  Natalie S Hauser; Benjamin D Solomon; Thierry Vilboux; Alina Khromykh; Rajiv Baveja; Dale L Bodian
Journal:  Mol Genet Genomic Med       Date:  2018-01-25       Impact factor: 2.183

Review 9.  MicroRNAs in congenital heart disease.

Authors:  Tanya Smith; Cha Rajakaruna; Massimo Caputo; Costanza Emanueli
Journal:  Ann Transl Med       Date:  2015-12

10.  Characterization of circulating microRNA expression in patients with a ventricular septal defect.

Authors:  Dong Li; Long Ji; Lianbo Liu; Yizhi Liu; Haifeng Hou; Kunkun Yu; Qiang Sun; Zhongtang Zhao
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.